News & Updates

Show Multimedia Only

Higher echocardiographic calcium score seen in CVD patients on peritoneal dialysis

24 May 2022 by

Patients undergoing peritoneal dialysis (PD) with cardiovascular disease (CVD) show significantly higher echocardiographic calcium score (ECS) than those without CVD, according to a Singapore study. This indicates a higher vascular calcification burden in the former.

Higher echocardiographic calcium score seen in CVD patients on peritoneal dialysis

24 May 2022

CIEDs give clues to time of patient death

24 May 2022 by

Postmortem interrogation of cardiac implantable electrical devices (CIED) can help pinpoint a patient’s time of death, according to a recent study. While forensic analysis of explanted CIEDs is valid, accuracy of time determination varies across different devices.

CIEDs give clues to time of patient death

24 May 2022

‘1-2-3-4-day rule’: Initiating DOACs according to stroke severity may be the way to go

23 May 2022 by

Following nonvalvular atrial fibrillation (NVAF)-associated stroke events, a graded increase in delay in direct oral anticoagulants (DOACs) initiation of between 1 and 4 days, depending on the severity of the index event, appears to be effective for recurrent stroke prevention and does not compromise safety both in Asians and Europeans, according to a recent study.

‘1-2-3-4-day rule’: Initiating DOACs according to stroke severity may be the way to go

23 May 2022

Intensive BP management reduces CVD deaths in overweight, obese patients

23 May 2022 by

Intensive management of blood pressure (BP) leads to a significant reduction in cardiovascular events in overweight, obese I, and obese II patients without elevating safety risks, a study has shown.

Intensive BP management reduces CVD deaths in overweight, obese patients

23 May 2022

High BNP predicts stroke or systemic embolism in very elderly NVAF patients

22 May 2022

In very elderly nonvalvular atrial fibrillation (NVAF) patients who are ineligible for standard anticoagulation, increasing levels of B-type natriuretic peptide (BNP) appear to be correlated with higher risks of stroke or systemic embolism, reports a new study.

High BNP predicts stroke or systemic embolism in very elderly NVAF patients

22 May 2022

Which canagliflozin dose is best for T2DM patients with hypertension?

22 May 2022

A recent meta-analysis offers new proof of different canagliflozin doses for hypertension management in patients with type 2 diabetes mellitus (T2DM) complicated by hypertension. However, low-density lipoprotein cholesterol (LDL-C) and the risk of urinary tract infection must be observed.

Which canagliflozin dose is best for T2DM patients with hypertension?

22 May 2022

Conduction disturbances common after new-generation self-expanding valve implantation

22 May 2022

Implantation with new-generation, self-expanding aortic valves appears to result in a significant spike in the rates of high-degree cardiac conduction disturbance, such as an increase in PR and QRS intervals, reports a new study.

Conduction disturbances common after new-generation self-expanding valve implantation

22 May 2022

Early evolocumab helps reduce LDL-C levels, prevent recurrent ischaemic cardiovascular events

21 May 2022

In acute coronary syndrome (ACS) patients who have undergone percutaneous coronary intervention (PCI), early treatment with evolocumab as an addition to statin can lower low-density lipoprotein cholesterol (LDL-C) levels as well as reduce the incidence of recurrent ischemic cardiovascular events, while having satisfactory tolerability and safety, according to a study.

Early evolocumab helps reduce LDL-C levels, prevent recurrent ischaemic cardiovascular events

21 May 2022

Isolated systolic hypertension tied to increased LV mass index, aortic stiffness in adolescents

21 May 2022

Adolescents with isolated systolic hypertension (ISH), including the spurious hypertension (sHTN) subtype, show more noticeable markers of cardiac end-organ damage, higher aortic stiffness, and stroke volume than those with white-coat hypertension (WCH), a study has shown.

Isolated systolic hypertension tied to increased LV mass index, aortic stiffness in adolescents

21 May 2022

Late nonfasting plasma glucose tied to CVD deaths

21 May 2022

The risks of cardiovascular disease (CVD) mortality appear to be higher among adults with elevated late nonfasting plasma glucose (PG) levels independently of glycated haemoglobin (HbA1c), a recent study reports.

Late nonfasting plasma glucose tied to CVD deaths

21 May 2022

News & Updates

Filter by Specialty:

Specialty:

Higher echocardiographic calcium score seen in CVD patients on peritoneal dialysis

Higher echocardiographic calcium score seen in CVD patients on peritoneal dialysis

CIEDs give clues to time of patient death

CIEDs give clues to time of patient death

‘1-2-3-4-day rule’: Initiating DOACs according to stroke severity may be the way to go

‘1-2-3-4-day rule’: Initiating DOACs according to stroke severity may be the way to go

Intensive BP management reduces CVD deaths in overweight, obese patients

Intensive BP management reduces CVD deaths in overweight, obese patients

High BNP predicts stroke or systemic embolism in very elderly NVAF patients

High BNP predicts stroke or systemic embolism in very elderly NVAF patients

Which canagliflozin dose is best for T2DM patients with hypertension?

Which canagliflozin dose is best for T2DM patients with hypertension?

Conduction disturbances common after new-generation self-expanding valve implantation

Conduction disturbances common after new-generation self-expanding valve implantation

Early evolocumab helps reduce LDL-C levels, prevent recurrent ischaemic cardiovascular events

Early evolocumab helps reduce LDL-C levels, prevent recurrent ischaemic cardiovascular events

Isolated systolic hypertension tied to increased LV mass index, aortic stiffness in adolescents

Isolated systolic hypertension tied to increased LV mass index, aortic stiffness in adolescents

Late nonfasting plasma glucose tied to CVD deaths

Late nonfasting plasma glucose tied to CVD deaths